Association between anti-thymocyte globulin administration and cytomegalic virus infection and/or CMV disease in cadaveric renal allograft recipients.
暂无分享,去创建一个
[1] B. Kasiske,et al. A randomized trial comparing cyclosporine induction with sequential therapy in renal transplant recipients , 1997 .
[2] H. Krueger,et al. THE COST IMPACT OF CYTOMEGALOVIRUS DISEASE IN RENAL TRANSPLANT RECIPIENTS , 1993, Transplantation.
[3] D. O'donoghue,et al. A prospective study of prophylactic ATG versus cyclosporine in regrafted and highly sensitized renal allograft recipients. , 1990, Transplantation.
[4] R. Atkins,et al. CYTOMEGALOVIRUS INFECTION COMPLICATING RENAL TRANSPLANTATION AND ITS RELATIONSHIP TO ACUTE TRANSPLANT GLOMERULOPATHY , 1988, Transplantation.
[5] D. Sutherland,et al. THE EFFECTS OF DELAYED FUNCTION OF RECIPIENTS OF CADAVER RENAL ALLOGRAFTS: A STUDY OF 158 PATIENTS RANDOMIZED TO CYCLOSPORINE OR ALG‐AZATHIOPRINE , 1986, Transplantation.
[6] H. Friedman,et al. The role of pretransplant immunity in protection from cytomegalovirus disease following renal transplantation. , 1985, Transplantation.
[7] R. Filo,et al. Reversal of acute renal allograft rejection with adjunctive AG therapy. , 1981, Transplantation proceedings.
[8] Hill Mm. Living organisms in patent law. , 1970 .